Bupa CareConnect is presenting an advanced healthcare model for the Hajj Season 2025
Makkah:In a significant step toward redefining healthcare delivery during Hajj, Bupa CareConnect, the healthcare arm of Bupa Arabia, launched its first ever field based 'Bupa Clinics' in Mina from June 4 to 9. This initiative marked a landmark expansion of Bupa Arabia's services beyond corporate campuses, bringing integrated, tech-enabled medical care directly to pilgrims during one of the most spiritually significant gatherings in the world.Field-Based CareAs part of its social responsibility strategy, the "Bupa Clinics" initiative was launched in coordination with Urgent Care Centers under the supervision of the Ministry of Health. The initiative aimed to provide primary healthcare services to all pilgrims — both Bupa members and non-members, the Mina based clinics offered comprehensive primary healthcare services around the clock. Strategically positioned near essential amenities such as Al-Dawaa Pharmacy, the clinics ensured accessible, responsive care to support the wellbeing of pilgrims within the sacred sites.1,368 Medical Cases Handled with Round-the-Clock ExpertiseOperating 24/7 throughout the Hajj season, the clinics recorded a total of 1,368 medical interactions. Male pilgrims represented 75% of the cases, while female patients accounted for 25%. The facility was staffed by a dedicated medical team of six doctors and three nurses, working in rotational shifts to guarantee continuous readiness and rapid response.Health services ranged from vital signs monitoring and management of heat exhaustion, to chronic illness care and emergency triage. Notably, 20 patients were transferred to the Armed Forces Hospital in Mina for advanced treatment, while one critical case required urgent life-saving intervention, underscoring the preparedness and responsiveness of the team.Pilgrims sought care for a wide spectrum of conditions, including headaches, fatigue, skin infections, joint pain, conjunctivitis, gastrointestinal discomfort, heatstroke, and minor injuries. The clinics prioritized culturally sensitive and timely care, with special attention to the elderly and individuals with chronic conditions.Technology at the Core of Care DeliveryThe clinics were equipped with advanced medical tools such as ECG machines, digital blood pressure monitors, and glucose meters. All systems were seamlessly connected to Bupa Arabia's unified digital health platform, enhancing the accuracy of diagnoses, improving case documentation, and streamlining patient referrals.Beyond physical health, mental health support and health education were key components of the initiative. The clinics adopted a holistic approach to healthcare, blending digital innovation with compassionate service to deliver a full-spectrum care experience on the ground.A Strategic Expansion Beyond Corporate BoundariesThis deployment marked the first time that Bupa Clinics operated outside their regular corporate client locations, previously limited to key sites such as SABIC, Savola, the King Abdullah Financial District (KAFD), and the National Housing Company. With their presence in Mina, Bupa CareConnect extended its reach to Saudi Arabia's largest annual gathering, affirming its commitment to inclusive and scalable healthcare solutions.Leadership Perspectives on the Milestone InitiativeCommenting on the initiative, Bupa Arabia CEO Tal Nazer said: 'We are honored to bring Bupa Clinics to Hajj for the first time, offering advanced, people-centric care to the Guests of Allah, both members and non-members regardless of insurance status. This reflects our mission to expand access to quality healthcare and deliver services where they're most needed, through an integrated model driven by innovation and compassion.'Proactive careDr. Abdullah Khafagy, Executive Medical Director at Bupa CareConnect, added: 'Hajj is a spiritual journey that presents unique medical challenges, and the Bupa Clinics allowed us to respond proactively, providing early screenings, preventive care, and timely interventions in the heart of Mina. This initiative is a testament to our healthcare philosophy, proactive, accessible, and centered on human dignity.'Supporting Vision 2030 Through Integrated, Impact-Driven CareThe Bupa Clinics initiative aligns with the Kingdom's Vision 2030 goals to enhance the quality of life and boost the private sector's role in public health. The project stands as a model of integrated, preventive, and curative care tailored for large-scale public gatherings.It also reinforces Bupa Arabia's commitment to corporate social responsibility through its Integrated Care Program, an approach that places individuals at the center of the healthcare journey, emphasizing awareness, early detection, and continuity of care.Pioneering Digital Transformation in HealthcareBupa Arabia continues to lead the way in healthcare innovation across the Kingdom. The company has introduced mobile digital clinics to expand access to remote areas and launched the 'Bupa App,' which allows users to manage their full health journey, from booking appointments and virtual consultations to continuous monitoring and follow-up care.In a groundbreaking move, Bupa Arabia also launched 'without approvals' the first health insurance program in Saudi Arabia to eliminate pre-approval requirements. Powered by AI, Bupa Pro enhances the efficiency of claims processing and improves the overall patient experience by removing bureaucratic hurdles.
Through this pioneering initiative in Mina, Bupa Arabia has once again demonstrated its role as a leader in health innovation, delivering on its mission to provide inclusive, technology-driven, and compassionate care to all segments of society, especially during moments of profound spiritual importance like Hajj.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Bawaba
2 days ago
- Al Bawaba
The Department of Health – Abu Dhabi and Abbott Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi
Department of Health -Abu Dhabi is the regulative body of the Healthcare Sector in the Emirate of Abu Dhabi and ensures excellence in Healthcare for the community by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition DoH shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world – class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programs to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system in the Emirate of Abu Dhabi.
Al Bawaba
3 days ago
- Al Bawaba
The Department of Health – Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of Understanding (MoU) with Sanofi, a research and development-driven, AI-powered healthcare biopharma company at the BIO International Convention 2025, in Boston, USA. The collaboration will leverage the Emirate's health-tech ecosystem and advanced research infrastructure to drive the development of new global vaccines and strengthen regional capabilities in vaccine manufacturing. In the presence of H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi and Laurie Gery. Global Head of Business Development, Vaccines at Sanofi, the agreement was signed during the BIO International Convention in Boston, USA, by Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH and Baptiste de Clarens, General Manager Greater Gulf, Vaccines at Sanofi. Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH, said: 'DoH is partnering with Sanofi to expedite the development of new global vaccines. This initiative aims to shorten the timeline from early research to public availability by utilising advanced technologies, real-time data analysis, and conducting parallel clinical trial phases. By combining Sanofi's global scientific expertise with Abu Dhabi's state-of-the-art infrastructure, we set new benchmarks for resilience, innovation and international partnerships. Abu Dhabi offers a globally connected, purpose-driven environment for leading research and together we will drive a transformative change that will safeguard the health and well-being of our community while contributing to global health security.' Both entities will work together to streamline regulatory processes, enhance manufacturing preparedness, and promote knowledge sharing between local and international experts. This partnership reflects Abu Dhabi's strategic goal to establish itself as a leading center for bio- and pharmaceutical innovation and underscores the emirate's commitment to advancing proactive, technology-driven healthcare solutions. Baptiste de Clarens, General Manager Greater Gulf, Vaccines, Sanofi, said: 'The Memorandum of Understanding signed with the Department of Health – Abu Dhabi marks an encouraging step towards advancing global health security while reflecting our shared interest in addressing global health challenges through scientific partnership. This agreement allows us to examine how Sanofi's experience in vaccine development could complement Abu Dhabi's growing R&D ecosystem. Through this initial framework, we look forward to exploring opportunities for public-private collaboration in healthcare innovation.' In addition, both the Department and Sanofi will advance clinical research and development planning, optimise resource allocation and establish the foundational terms for funding and access. These efforts are designed to enhance healthcare resilience and sustainability across Abu Dhabi's healthcare sector and beyond, expanding access to quality care for patients locally and globally. Led by DoH, a high-level delegation has embarked on a strategic mission to the United States from June 15 to 21, delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo, New York University Abu Dhabi (NYUAD), Khalifa University, startAD and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI).
Al Bawaba
5 days ago
- Al Bawaba
DoH and Boehringer Ingelheim Ink Strategic Partnership to Advance Life Science Innovation Across the Emirate
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, one of the world's leading research-driven pharmaceutical companies. This strategic partnership aims to advance scientific research and innovation, foster groundbreaking research and development and cultivate an environment of scientific excellence, further cementing the Emirate as the MENA region's premier hub for healthcare, life sciences and innovation. In the presence of H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi and Ousama Alhaj, General Manager and Head of Human Pharma, Near East and UAE at BI, the agreement was signed during BIO International Convention in Boston at the Abu Dhabi Pavilion by Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH and Ghaleb Al Ahdab, Head of Public and Government Affairs, Near East and UAE at this strategic partnership, the two parties seek to strengthen the Emirate's research ecosystem by facilitating access to and harnessing the capabilities of Boehringer Ingelheim's OpnME platform. Researchers, scientists and innovators across Abu Dhabi will be able to leverage the platform's cutting-edge data and resources to address critical biological challenges and accelerate scientific discovery. Through four flagship programmes, Molecule to Order (M2O), Molecule for Collaboration (M4C), opn2EXPERTS (o2e) and opnTALENTS (o25), the platform empowers the research community with access to advanced compounds, collaborative opportunities, expert networks and support for emerging talent. OpnME connects visionary researchers to champion transformative, research-driven medical innovation for generations to come. In line with Abu Dhabi's vision to shape the future of healthcare, this partnership between DoH and BI enhances knowledge exchange and invests in local talent. It offers scientists a purpose-driven, globally connected environment to lead impactful research, further reinforcing the Emirate's commitment to transforming the regional healthcare ecosystem through science and technology. Dr. Asma Ibrahim Al Mannaei, the Executive Director of the Health Life Sciences Sector at DoH, said: 'Our partnership with Boehringer Ingelheim reflects our commitment to pioneering innovation and scientific research as parts of our efforts to advance health outcomes and improve the quality of life for communities around the world. We're empowering Abu Dhabi researchers with the opnMe platform, an open portal offering top-tier pharmaceutical compounds, fostering collaboration and safeguarding researchers' rights to their findings. This is about transforming our emirate into a global life sciences hub, speeding up breakthroughs, and building a healthier, resilient future for all.'Ousama Alhaj, General Manager and Head of Human Pharma for Near East and UAE at Boehringer Ingelheim, said: 'At Boehringer Ingelheim, we are proud to partner with the Department of Health – Abu Dhabi (DoH) to empower the scientific community through our OpnMe platform. This collaboration reflects our shared commitment to advancing research and innovation in the region, fostering a culture of discovery, and ultimately improving patient outcomes. By providing access to our scientific resources, including advanced compounds, collaborative research opportunities, and expert networks, we aim to inspire new ideas and support the next generation of researchers in Abu Dhabi.' Led by DoH, a high-level delegation has embarked on a strategic mission to the United States from June 14 to 21, delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo, New York University Abu Dhabi (NYUAD), Khalifa University, startAD and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI).
